Malignant gliomas of the cerebellum: an analytic review
- PMID: 9524103
- DOI: 10.1023/a:1005704006244
Malignant gliomas of the cerebellum: an analytic review
Abstract
Using an analytical review, the demographic data on malignant cerebellar gliomas such as length of survival, and those factors associated with prolonged survival were examined. Seventy-one cases of malignant cerebellar glioma reported since 1975 were combined and reviewed with the seven cases treated at our institution since that time. Thirty-seven patients (47%) had grade III tumors and 41 (53%) had grade IV tumors. Fifty-nine percent of the tumors were located in the hemispheres and 41% were found in the vermis. Median survival for patients with grade III anaplastic astrocytomas was 32 months compared to 11 months for those with grade IV glioblastomas multiforme (P = 0.0257). For the entire cohort, patients with grade III tumors, those who had a surgical resection, and those that had received radiation therapy for treatment of their tumor had prolonged survival on multivariable analysis. Radiation therapy was associated with extended survival for patients with grade III tumors by uni- and multivariate analysis. For grade IV tumors, univariate analysis revealed prolonged survival for those patients who had surgical resection compared to those who had biopsy alone (P = 0.0036) and for those who received external beam radiation therapy (P = 0.0001). Patients with malignant gliomas of the cerebellum had length of survival comparable to their supratentorial counterparts. Prompt diagnosis and treatment may explain the similarity in survival found between supra- and infratentorial malignant gliomas despite an expected shorter survival because of treatment limitations. Surgical resection followed by radiation therapy is recommended for patients with malignant gliomas of the cerebellum.
Similar articles
-
Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome.J Neurosurg. 1993 May;78(5):767-75. doi: 10.3171/jns.1993.78.5.0767. J Neurosurg. 1993. PMID: 8468607
-
Improved survival in the largest national cohort of adults with cerebellar versus supratentorial low-grade astrocytomas.Neurosurg Focus. 2013 Feb;34(2):E7. doi: 10.3171/2012.12.FOCUS12343. Neurosurg Focus. 2013. PMID: 23373452
-
Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project.J Neurosurg. 2003 Sep;99(3):467-73. doi: 10.3171/jns.2003.99.3.0467. J Neurosurg. 2003. PMID: 12959431
-
Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?Strahlenther Onkol. 2004 Jul;180(7):401-7. doi: 10.1007/s00066-004-1220-7. Strahlenther Onkol. 2004. PMID: 15241527 Review.
-
Low-grade gliomas -- current concepts.Zentralbl Neurochir. 2006 May;67(2):55-66. doi: 10.1055/s-2006-933408. Zentralbl Neurochir. 2006. PMID: 16673237 Review.
Cited by
-
Leptomeningeal dissemination of cerebellar malignant astrocytomas.J Neurooncol. 2003 Jun;63(2):191-9. doi: 10.1023/a:1023983518341. J Neurooncol. 2003. PMID: 12825824
-
Epidemiologic and molecular prognostic review of glioblastoma.Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):1985-96. doi: 10.1158/1055-9965.EPI-14-0275. Epub 2014 Jul 22. Cancer Epidemiol Biomarkers Prev. 2014. PMID: 25053711 Free PMC article. Review.
-
Discernable differences in the genetic and molecular profile of cerebellar glioblastoma.Transl Cancer Res. 2019 Dec;8(Suppl 6):S553-S558. doi: 10.21037/tcr.2019.08.24. Transl Cancer Res. 2019. PMID: 35117131 Free PMC article. No abstract available.
-
Investigating distinct clinical features and constructing a nomogram model for survival probability in adults with cerebellar high-grade gliomas.BMC Cancer. 2024 Jul 13;24(1):836. doi: 10.1186/s12885-024-12580-4. BMC Cancer. 2024. PMID: 39003457 Free PMC article.
-
Cerebellar glioblastoma: a retrospective review of 21 patients at a single institution.J Neurooncol. 2011 Dec;105(3):555-62. doi: 10.1007/s11060-011-0617-2. Epub 2011 Jun 4. J Neurooncol. 2011. PMID: 21643841 Review.